Marcus Reif
Impact in
- Pharmacology top 1%
- Cannabis and Cannabinoid Research
- Toxicology top 5%
Papers in
- Oncology 21
- Cancer survivorship and care 19
- Cancer Treatment and Pharmacology 4
- Immunology 12
- Toxin Mechanisms and Immunotoxins 11
- Co-authors
- Martin Schnelle (3 shared papers)Diana Lüftner (1 shared paper)Thomas Ruhstaller (1 shared paper)Thomas Cerny (1 shared paper)Matthias Kröz (26 shared papers)Kurt Possinger (1 shared paper)Winfried Meißner (1 shared paper)Florian Strasser (1 shared paper)
- Journals
- Complementary Therapies in Medicine (4 papers)Phytomedicine (4 papers)Integrative Cancer Therapies (3 papers)Journal of Clinical Oncology (3 papers)BMC Cancer (2 papers)
- Partner nations
- GermanyUnited KingdomSwitzerland
In The Last Decade
Marcus Reif
57 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 110
- Pharmacology 555
- Toxicology 44
- Immunology 184
- Cellular and Molecular Neuroscience 160
- Oncology 220
Countries citing papers authored by Marcus Reif
This map shows the geographic impact of Marcus Reif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Reif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Reif more than expected).
Fields of papers citing papers by Marcus Reif
This network shows the impact of papers produced by Marcus Reif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Reif. The network helps show where Marcus Reif may publish in the future.
Co-authors
The 25 scholars most cited alongside Marcus Reif, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 297 | |
| 2 | 2004 | 185 | |
| 3 | 2002 | 151 | |
| 4 | 2013 | 125 | |
| 5 | 2008 | 100 | |
| 6 | 2012 | 50 | |
| 7 | 2017 | 49 | |
| 8 | 1999 | 47 | |
| 9 | 2007 | 45 | |
| 10 | Tolerability of an extract of European mistletoe among immunocompromised and healthy individuals. | 1999 | 43 |
| 11 | 2008 | 33 | |
| 12 | 2002 | 29 | |
| 13 | 2012 | 24 | |
| 14 | 2011 | 24 | |
| 15 | 2009 | 22 | |
| 16 | 2014 | 22 | |
| 17 | 2018 | 20 | |
| 18 | 2011 | 13 | |
| 19 | 2012 | 11 | |
| 20 | 2011 | 10 |
About Marcus Reif
Marcus Reif is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Molecular Biology, having authored 60 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer survivorship and care (19 papers), Toxin Mechanisms and Immunotoxins (11 papers), Cancer-related cognitive impairment studies (8 papers), Childhood Cancer Survivors' Quality of Life (7 papers), Plant tissue culture and regeneration (6 papers), Cannabis and Cannabinoid Research (5 papers), Health, psychology, and well-being (5 papers) and Cancer Treatment and Pharmacology (4 papers). The work is most often cited by research in Pharmacology (555 citations), Toxicology (44 citations), Immunology (184 citations), Cellular and Molecular Neuroscience (160 citations) and Oncology (220 citations). Marcus Reif has collaborated with scholars based in Germany, United Kingdom and Switzerland. Frequent co-authors include Martin Schnelle, Diana Lüftner, Thomas Ruhstaller, Thomas Cerny, Matthias Kröz, Kurt Possinger, Winfried Meißner, Florian Strasser, Gernot Ernst and Roland Zerm. Their work appears in journals such as Complementary Therapies in Medicine, Phytomedicine, Integrative Cancer Therapies, Journal of Clinical Oncology and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.